https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-10-14 14:17:412016-11-24 12:46:58Astex Pharmaceuticals to Present at AACR-NCI-EORTC
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-09-30 14:21:122016-11-24 12:47:29Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-09-05 12:04:242016-12-02 14:29:11Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals for $8.50 Per Share in Cash
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-08-28 14:22:372016-11-24 12:47:49Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-07-29 16:16:592016-11-24 12:49:01Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-07-22 16:19:202016-11-24 12:49:35Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of Resistance in Preclinical Models
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2013-06-20 16:24:592016-12-01 16:37:03Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
